SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Drug Works Well For Moderate-To-Severe Psoriasis; Ustekinumab Injections Every 3 Months A More Convenient Regimen Than Current Therapies, University of Texas Health Science Center Study
May 19, 2008
 · 
1 min read
Lone Star Bio
New Therapy Kills Human Leukemia Cells in Mice, University of Texas Study
May 19, 2008
 · 
1 min read
Lone Star Bio
Weight-Loss Aids Bought On Internet Might Harm Your Heart; Pills, Supplements Have Potentially Dangerous Ingredients, Lack Warning Labels, St. Luke’s Episcopal Hospital Study Finds
May 16, 2008
 · 
1 min read
Drug Development
Drug Combo of Herceptin and Tykerb Helps Women With Advanced Breast Cancer, Baylor-Sammons Cancer Center Study
May 16, 2008
 · 
1 min read
Lone Star Bio
Molecular ‘Clock’ Could Predict Risk For Developing Breast Cancer, UT Southwestern Medical Center Study
May 14, 2008
 · 
1 min read
Lone Star Bio
New MRI Technique Detects Subtle Brain Injuries, UT Southwestern Medical Center Study
May 13, 2008
 · 
1 min read
Policy
Drug Company Executives from Johnson & Johnson, Pfizer Inc., and a joint-venture between Merck & Co., Inc. and Schering-Plough Corporation Respond To Concerns About Ads At House Panel Hearing
May 13, 2008
 · 
1 min read
Lone Star Bio
High Fat Diet Linked To Prostate Cancer, M. D. Anderson Cancer Center Study
May 9, 2008
 · 
1 min read
Lone Star Bio
Unexpected Role: EGFR Protects Cancer Cells From Starving, University of Texas M. D. Anderson Cancer Center Study
May 7, 2008
 · 
1 min read
Lone Star Bio
Protein ‘Nixes’ Mitochrondria, Prompts Maturation Of Red Blood Cells, Baylor College of Medicine Study
May 5, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
November 21, 2025
 · 
1 min read
Press Releases
CrossBridge Bio Awarded $15 Million CPRIT Grant to Advance CBB-120, Its Lead Dual-Payload ADC Targeting TROP-2, Into the Clinic
November 21, 2025
 · 
2 min read
Press Releases
Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface
November 21, 2025
 · 
4 min read
Press Releases
Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets
November 21, 2025
 · 
3 min read
Press Releases
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
November 21, 2025
 · 
5 min read
Press Releases
Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board
November 20, 2025
 · 
3 min read
Press Releases
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Press Releases
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
November 20, 2025
 · 
4 min read
Press Releases
Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics
November 20, 2025
 · 
3 min read
Press Releases
EMILY SEDGWICK, M.D., NAMED CHIEF MEDICAL OFFICER OF SOLIS MAMMOGRAPHY
November 20, 2025
 · 
3 min read
Load More